Skip to main content

and
  1. Article

    Open Access

    Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study

    Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV) disease and inflammation in chronic inflammatory conditions different from axial spondyloarthritis (axSpA). Given the high inci...

    Javier Rueda-Gotor, Raquel López-Mejías in Arthritis Research & Therapy (2021)

  2. No Access

    Article

    The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors

    To investigate the effect of concomitant conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) with adalimumab or infliximab on maintaining serum drug and clinical outcomes after the first y...

    Ana Martínez-Feito, Chamaida Plasencia-Rodríguez in Clinical Rheumatology (2019)

  3. Article

    Open Access

    Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis

    The aim of our study was to investigate the influence of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and body mass index (BMI) on circulating drug levels and clinical response to t...

    Borja Hernández-Breijo, Chamaida Plasencia-Rodríguez in Arthritis Research & Therapy (2019)

  4. No Access

    Chapter

    Opportunistic Infections Associated with Biologic Therapy

    Opportunistic infections are a severe complication in immunocompromised patients and in those receiving treatments that impair the homeostasis of the immunologic system. Biologics to treat autoimmune disorders...

    Emilio Martín-Mola, Chamaida Plasencia-Rodríguez in Infections and the Rheumatic Diseases (2019)